跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
吡仑帕奈口服混悬液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Perampanel Oral Suspension
Approved
化学药品
Perampanel Oral Suspension
EISAI EUROPE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 12, 2023
Approval ID
1z32eaodlQC
Company
EISAI EUROPE LIMITED
Type
化学药品
Approval Details
Approval Id
1z32eaodlQC
Approval Number
国药准字HJ20230052
Generic Name
吡仑帕奈口服混悬液
Generic Name En
Perampanel Oral Suspension
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
340ml:170mg
Reg Date
2023-05-12
Expired Date
2028-05-11
Company Name
EISAI EUROPE LIMITED
Production Company Name
DELPHARM HUNINGUE SAS
Company Detail Path
/organization/eisai-europe-limited
Production Company Detail Path
/organization/delpharm-huningue-sas
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 12, 2023
Approval ID
1z32eaodlQC
Type
化学药品
Back to NMPA Approvals